Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
作者： Philippe Rougier , Eric Van Cutsem , Emilio Bajetta , Norbert Niederle , Kurt Possinger
DOI: 10.1016/S0140-6736(98)03085-2
关键词:
摘要: … months, respectively (p=0·059, figure 4). The probability of pain-free survival in the iriontecan … with a 24% probability of being free from progression at 6 months. Furthermore, the median …
ulb.ac.be
elsevier.com
sci-hub.se 参考文章(17)
H C Pitot, D B Wender, M J O'Connell, G Schroeder, R M Goldberg, J Rubin, J A Mailliard, J A Knost, C Ghosh, R J Kirschling, R Levitt, H E Windschitl, Phase II Trial of Irinotecan in Patients With Metastatic Colorectal Carcinoma Journal of Clinical Oncology. ,vol. 15, pp. 2910- 2919 ,(1997) , 10.1200/JCO.1997.15.8.2910
P. Diehr, D. Patrick, T. E. Raghunathan, S. Beresford, S. Hedrick, D. Grembowski, M. Rothman, Including Deaths When Measuring Health Status Over Time Medical Care. ,vol. 33, ,(1995)
A F Sobrero, C Aschele, J R Bertino, Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation. Journal of Clinical Oncology. ,vol. 15, pp. 368- 381 ,(1997) , 10.1200/JCO.1997.15.1.368
P Rougier, R Bugat, J Y Douillard, S Culine, E Suc, P Brunet, Y Becouarn, M Ychou, M Marty, J M Extra, J Bonneterre, A Adenis, J F Seitz, G Ganem, M Namer, T Conroy, S Negrier, Y Merrouche, F Burki, M Mousseau, P Herait, M Mahjoubi, Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 251- 260 ,(1997) , 10.1200/JCO.1997.15.1.251
A de Gramont, J F Bosset, C Milan, P Rougier, O Bouché, P L Etienne, F Morvan, C Louvet, T Guillot, E François, L Bedenne, Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Journal of Clinical Oncology. ,vol. 15, pp. 808- 815 ,(1997) , 10.1200/JCO.1997.15.2.808
R. Hansen, E. Quebbeman, R. Ausman, J. Frick, P. Ritch, W. Schulte, C. Haas, P. Beatty, T. Anderson, Continuous systemic 5-fluorouracil infusion in advanced colorectal cancer: results in 91 patients. Journal of Surgical Oncology. ,vol. 40, pp. 177- 181 ,(1989) , 10.1002/JSO.2930400309
W Scheithauer, H Rosen, G V Kornek, C Sebesta, D Depisch, Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. ,vol. 306, pp. 752- 755 ,(1993) , 10.1136/BMJ.306.6880.752
E. Jäger, O. Klein, B. Wächter, B. Müller, U. Braun, A. Knuth, High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: Results of a phase II study European Journal of Cancer. ,vol. 31, pp. 1717- 1717 ,(1995) , 10.1016/0959-8049(95)00238-E
N. Kemeny, D. Niedzwiecki, B. Shurgot, P. Oderman, Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer. ,vol. 63, pp. 742- 747 ,(1989) , 10.1002/1097-0142(19890215)63:4<742::AID-CNCR2820630423>3.0.CO;2-T
Stuart J. Pocock, Richard Simon, Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial Biometrics. ,vol. 31, pp. 103- 115 ,(1975) , 10.2307/2529712